Discovery of highly potent and selective KAT6A degraders that demonstrates robust anti-tumor activities in preclinical studies
Hanyu Wang, Lei Jiang, Youxi Chen, Baoying Cheng, Yuyao Zhang, Nianfeng Huang, Fan Yang, Feng Zhou
Atheron Therapeutics (Shanghai), Ltd